# BioNTech will transfer production of its COVID-19 vaccine to partner Pfizer this year.

*biotech · news · 2026-05-05 · Devdiscourse*

## Key points

- BioNTech will close production facilities in Germany and Singapore by 2027.
- Up to 1,860 jobs at BioNTech may be affected by these site closures.
- Production of BioNTech’s COVID-19 vaccine will transfer to Pfizer this year.
- BioNTech expects to save about 500 million euros annually by 2029 from these changes.
- BioNTech plans a share buyback of up to $1 billion over the next year.

**Companies:** Pfizer, BioNTech
**Countries:** Germany, Singapore

[Read the full story on Devdiscourse](https://www.devdiscourse.com/article/health/3897198-biontech-announces-major-site-closures-amid-executive-departures)

---

Canonical: https://newsio.io/n/13f1723c-db98-4313-8de6-751e6a864714/biontech-will-transfer-production-of-its-covid-19-vaccine-to-partner-pfizer-this
Summarized by Newsio from Devdiscourse. https://newsio.io/how-it-works